| Market Cap | 4.98M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -3.08M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -17.00% |
| Sales | 162.22k | PEG | - | EPS past 5Y | - | 200D Avg Chg | 28.00% |
| Dividend | N/A | Price/Book | 10.82 | EPS next 5Y | - | 52W High Chg | -52.00% |
| Recommedations | - | Quick Ratio | 0.82 | Shares Outstanding | 119.04M | 52W Low Chg | 225.00% |
| Insider Own | 24.47% | ROA | -88.73% | Shares Float | 54.31M | Beta | - |
| Inst Own | - | ROE | -822.20% | Shares Shorted/Prior | -/- | Price | 0.10 |
| Gross Margin | 100.00% | Profit Margin | - | Avg. Volume | 59,324 | Target Price | - |
| Oper. Margin | -2,184.23% | Earnings Date | - | Volume | 691 | Change | 14.12% |
AI/ML Innovations Inc. operates in the digital healthcare business using artificial intelligence (AI) and machine learning (ML). It offers a patent-pending personal health monitoring and management system for caregivers, patients, and healthcare professionals to access and utilize data for enhance recovery outcomes and healthy living, as well as digital health software and wearable technologies. The company was formerly known as AIML Resources Inc. and changed its name to AI/ML Innovations Inc. in November 2020. AI/ML Innovations Inc. was incorporated in 2009 and is headquartered in Victoria, Canada.
